The Future of Telehealth for Allergic Disease

J Allergy Clin Immunol Pract. 2022 Aug 26:S2213-2198(22)00827-3. doi: 10.1016/j.jaip.2022.08.022. Online ahead of print.

ABSTRACT

The COVID-19 pandemic ushered in an explosion in the use of telehealth. However, telehealth consists of much more than a video discussion between doctor and patient. Since the onset of the COVID-19 pandemic, allergists have demonstrated a high level of synchronous telemedicine adoption with existing patients but have not taken full advantage of other virtual care modalities that have the potential to facilitate the efficient delivery of allergy care to the broader population. This is partially due to a lack of awareness about the various remote care services, and how to appropriately implement and bill for them. This rostrum describes the spectrum of telehealth services, reviews existing literature on the use of telehealth in allergy, and provides suggestions on how allergists and immunologists can optimize the use of telehealth to not only optimize patient access and outcomes, but also receive appropriate compensation for specialty clinical services provided by themselves and their staff.

PMID:36038132 | DOI:10.1016/j.jaip.2022.08.022